Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha-Sha Li

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancer Management and Research|March 11, 2026
Impact of Surgical Wait Time on Survival After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort StudyQian Wang, Chang-Song Pei, Jing-Yi Cao, et al.
Food & Function|August 23, 2022
Diosgenin exerts an antihypertensive effect in spontaneously hypertensive rats <i>via</i> gut-brain communicationMeng-Lu Xu, Bo Peng, Juan Bai, et al.
Discover Oncology|March 5, 2026
IGF2BP3 promotes the muscle invasion of bladder cancer via PPARγ dysregulationJing-Yi Cao, Hua Peng, Guang-Yue Wang, et al.
Annals of Palliative Medicine|July 22, 2020
Quality of end-of-life care of advanced cancer patients in mainland China-a retrospective cohort of 441 hospital-death in a public funded comprehensive hospitalJi Shi Li, Tai-Chung Lam, Hai Man Jing, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2026
Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary CholangitisHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2026
Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' ReplyHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Journal of Ethnopharmacology|September 10, 2025
Biejia-Ruangan enhances the efficacy of entecavir in reversing liver cirrhosis in patients with chronic HBV infection: A seven-year open-label follow-up cohort studyXiao-Dong Wang, Fang-Fang Yi, Ping Huang, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2026
Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' ReplyHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2026
Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitisHong-Li Liu, Yi-Fan Hu, Miao-Yang Chen, et al.
BMC Gastroenterology|September 30, 2025
Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitisHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Management and Research|March 11, 2026
Impact of Surgical Wait Time on Survival After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort StudyQian Wang, Chang-Song Pei, Jing-Yi Cao, et al.
Food & Function|August 23, 2022
Diosgenin exerts an antihypertensive effect in spontaneously hypertensive rats <i>via</i> gut-brain communicationMeng-Lu Xu, Bo Peng, Juan Bai, et al.
Discover Oncology|March 5, 2026
IGF2BP3 promotes the muscle invasion of bladder cancer via PPARγ dysregulationJing-Yi Cao, Hua Peng, Guang-Yue Wang, et al.
Annals of Palliative Medicine|July 22, 2020
Quality of end-of-life care of advanced cancer patients in mainland China-a retrospective cohort of 441 hospital-death in a public funded comprehensive hospitalJi Shi Li, Tai-Chung Lam, Hai Man Jing, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2026
Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary CholangitisHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2026
Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' ReplyHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Journal of Ethnopharmacology|September 10, 2025
Biejia-Ruangan enhances the efficacy of entecavir in reversing liver cirrhosis in patients with chronic HBV infection: A seven-year open-label follow-up cohort studyXiao-Dong Wang, Fang-Fang Yi, Ping Huang, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2026
Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' ReplyHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2026
Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitisHong-Li Liu, Yi-Fan Hu, Miao-Yang Chen, et al.
BMC Gastroenterology|September 30, 2025
Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitisHong-Li Liu, Xing Liu, Yi-Fan Hu, et al.
Pageof 11